Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Methodology|Interests|Funding|Corrections
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Consultation record

Submissions accepted — page 5

The submission is accepted and the draft is amended as proposed. The amendment is recorded in the amendment log of the document it changed and is traceable to the numbered submission.

Submissions

735 documents · page 5 of 25

Table 1. Submissions with this disposition, on this page.

ReferenceConsultationRespondentPoint raised
DRAFT-THYROID-C-CE/009Draft safety review: the rodent thyroid C-cell signal and its human…Anselm MountstephenThe search strategy as published cannot be re-run
DRAFT-THYROID-C-CE/012Draft safety review: the rodent thyroid C-cell signal and its human…Dr Adaeze Underhill-OkaforResults at materially different follow-up durations are pooled
DRAFT-THYROID-C-CE/014Draft safety review: the rodent thyroid C-cell signal and its human…Dr Jerome PetrossianAn indirect comparison is presented without an assessment of transitivity
DRAFT-THYROID-C-CE/015Draft safety review: the rodent thyroid C-cell signal and its human…Dr Odalys Thorsby-NakamuraRisk-of-bias judgements are reported as an overall rating without the domains
DRAFT-THYROID-C-CE/016Draft safety review: the rodent thyroid C-cell signal and its human…Bertrand Ollerenshaw industryTwo factual descriptions of the sponsor's programme are inaccurate
DRAFT-SUPPLIER-DOS/001Draft format of the supplier dossier seriesDr Hyacinth Drakeford-AmadiA printed copy loses the information that makes it checkable
DRAFT-SUPPLIER-DOS/002Draft format of the supplier dossier seriesAnselm MountstephenAn identifier that encodes the document type will have to change when the type does
DRAFT-SUPPLIER-DOS/003Draft format of the supplier dossier seriesIvo MountstephenThe registry is published only as pages and not in a form that can be processed
DRAFT-SUPPLIER-DOS/004Draft format of the supplier dossier seriesStellan Cholmondeley-AdeThe citation format offered cites the document and not the part
DRAFT-SUPPLIER-DOS/006Draft format of the supplier dossier seriesQuentin Whitmarsh-ObiThe same quantity is presented differently in two series
DRAFT-SUPPLIER-DOS/007Draft format of the supplier dossier seriesDr Evander Whitmarsh-ObiQuantitative claims are reproduced without the method that produced them
DRAFT-SUPPLIER-DOS/009Draft format of the supplier dossier seriesDr Evander Ashworth-DanquahThe same concept is given three different names in one document
DRAFT-SUPPLIER-DOS/010Draft format of the supplier dossier seriesDr Ivo QuintanilhaThe index shows ratings without the reasons behind them
DRAFT-PEOPLE-REGIS/001Draft policy on the register of members and reviewersProfessor Bartolomeu Nkosi-LindegaardIndependence is asserted and the mechanism securing it is not described
DRAFT-PEOPLE-REGIS/003Draft policy on the register of members and reviewersDr Vasilisa Sandringham-AduWhat the site collects about a reader is not stated in terms a reader can check
DRAFT-PEOPLE-REGIS/005Draft policy on the register of members and reviewersQuentin Whitmarsh-ObiThe search date is not on the face of the document
DRAFT-PEOPLE-REGIS/007Draft policy on the register of members and reviewersDr Prosper VercingetorixNo period is stated within which a submission will be answered
DRAFT-PEOPLE-REGIS/009Draft policy on the register of members and reviewersKolawole Jankowiak-OseiThe position of a contributor who withdraws consent is not stated
DRAFT-PEOPLE-REGIS/010Draft policy on the register of members and reviewersDr Georgiana MountstephenWhether external reviewers are paid is not stated
DRAFT-PEOPLE-REGIS/012Draft policy on the register of members and reviewersDr Quentin EnthovenA party that is assessed and also sponsors should be disclosed on its own assessment
DRAFT-CORRECTIONS-/002Draft corrections and versioning policyDr Ludmila TollemacheWhere a document is generated rather than authored, the reader should be told
DRAFT-CORRECTIONS-/003Draft corrections and versioning policyDr Quentin Gwynne-SarpongNo term limit applies to membership of the assessment committee
DRAFT-CORRECTIONS-/005Draft corrections and versioning policyQuentin Whitmarsh-ObiNothing states what happens to the document set if the Institute ceases to operate
DRAFT-CORRECTIONS-/006Draft corrections and versioning policyDr Evander Whitmarsh-ObiQuantitative claims are reproduced without the method that produced them
DRAFT-CORRECTIONS-/008Draft corrections and versioning policyDr Rurik Haverkamp-DialloA party that is assessed and also sponsors should be disclosed on its own assessment
DRAFT-CORRECTIONS-/009Draft corrections and versioning policyDr Vasilisa Sandringham-AduAn industry submission should be identifiable without reading the declared interest
DRAFT-CORRECTIONS-/010Draft corrections and versioning policyWilhelmina Oppenheimer-AdeThe policy does not say who may make a submission
DRAFT-CORRECTIONS-/011Draft corrections and versioning policyVittoria YlönenA declared interest is published without being tested
DRAFT-CORRECTIONS-/013Draft corrections and versioning policyEamon Sandringham-AduThe terms on which the documents may be reused are not stated
DRAFT-CORRECTIONS-/014Draft corrections and versioning policyKolawole Jankowiak-OseiThe position of a contributor who withdraws consent is not stated

page 5 of 25

Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.